Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Data solutionsForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Index solutionsForge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Forge Thematic BasketsExplore focused views into key private market themesLiquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarEmerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Data solutions
Index solutions
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Trade private companies

Browse Biotech & Pharma Companies

Biotech focuses on infusing biological processes with technology to improve human, animal, and environmental health. Biotech & Pharma businesses utilize technology to work toward disease prevention, treatment and cure. These businesses also work in Agtech and fuel development. Register today to discover how Forge can help you buy and sell private shares.

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Less than $500MM
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Filters (3)
More (3)
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Less than $500MM
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Reset
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
GRIN TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$276.16MSeries D5/27/2025$140M$439.01M$1.79Angelini Pharma, Blackstone Life Sciences
MareaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$190MSeries B6/18/2024$152.89M$267.31M$1.45Sofinnova Investments, Forbion Capital Partners, Perceptive Advisors, venBio, Alpha Wave Global, Omega Funds, Citadel, Third Rock Ventures
Quanta TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$168.34MSeries D6/24/2026$76.19M$253.34M$1.44Avidity Partners, Sofinnova Investments, Vida Ventures, Surveyor Capital, Longitude Capital, BVF Partners, AbbVie Ventures, GC&H Investments, WS Investment Company
Seismic TherapeuticHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$470.32MSeries B12/4/2023$146.28M$396.35M$4.52Bessemer Venture Partners, Amgen Ventures, Codon Capital, Alexandria Venture Investments, Gaingels, GC&H, Timothy A. Springer, Lightspeed Venture Partners, Polaris Partners, Boxer Capital, GV, Samsara BioCapital
Tetherex PharmaceuticalsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$68.65MSeries B4/18/2018$63.95M$366.68M$21.32MPM Capital, Philip Jones
Third Arc BioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$197.75MSeries A7/16/2024$165M$305.43M$2.10Vida Ventures, Cormorant Asset Management, Hillhouse Investment, Omega Funds, Goldman Sachs, BVF Partners, T. Rowe Price Associates, Janus Henderson Investors, abrdn, Marshall Wace, Foresite Capital, Logos Capital, Freepoint Capital Group, AbbVie Ventures
TriGemX BioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$573.45MSeries E10/1/2026$93.99M$341.19M$0.79The Column Group, TCGX, Viking Global Investors
Tune TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$223.37MSeries B-11/13/2025$61.49M$355.58M$1.20New Enterprise Associates, Yosemite, Regeneron Ventures, Hevolution Foundation
Vanqua BioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$149.15MSeries B7/12/2024$130M$333.4M$4.06Omega Funds, OrbiMed, Citadel, Avoro Ventures, Casdin Capital, Pontifax, Eli Lilly and Company, Logos Capital, Osage University Partners
Aardvark TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$129.13MSeries C5/9/2024$85M$267.58M$1.77Decheng Capital, Cormorant Asset Management, Surveyor Capital, SymBiosis, Tetragon Financial Group, Walleye Capital, Laurion Capital Management, LG Technology Ventures, Cantor Ventures, Silver Arc Private Capital, Prader-Willi Syndrome Association, Vickers Venture Partners, Foundation for Prader-Willi Research
Asher BiotherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.05BSeries C4/16/2024$55M$428.78M$1.16RA Capital, AstraZeneca, Bristol Myers Squibb, Janus Henderson Investors, Third Rock Ventures, Wellington Management, Boxer Capital
Bicara TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$710.05MSeries C12/12/2023$165M$495.55M$1.38Braidwell LP, TPG, The Rise Fund, Deerfield Management, Fairmount, Aisling Capital, Red Tree Venture Capital, RA Capital Management, F-Prime Capital, Eight Roads Ventures, Invus Piper Heartland Healthcare Capital, Premji Invest, Omega Funds, Bioqube Ventures, Acorn Bioventures, Janus Henderson Investors
BioAgeHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.42BSeries D2/13/2024$170M$440.23M$3.42Sofinnova Investments, Longitude Capital, RA Capital, Cormorant Asset Management, RTW Investments, SV Health Investors, OrbiMed Advisors, Sands Capital, Pivotal bioVenture Partners, Osage University Partners, Lilly Ventures, Amgen Ventures, Andreessen Horowitz
BiomemeHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$18.33MSeries Seed-14/11/2022$5.46M$192.57M$5.93Undisclosed Investors
Dispatch BiotherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$179.79MSeries A7/23/2025$114M$270.29M$3.04ARCH Venture Partners, PICI, Bristol Myers Squibb, University of Pennsylvania, Stanford University, Alexandria Venture Investments
EnsomaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$250.75MSeries B-19/22/2025$45.2M$281.79M$1.09Gilead, 5AM Ventures, Catalio Capital Management, Cormorant Asset Management, Delos Capital, F-Prime Capital, Gates Foundation, Hanwha Impact Partners, Mirae Asset Financial Group, Qatar Investment Authority, RTW, Solasta Ventures, SymBiosis, Viking Global Investors
Epic SciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$606.66MSeries A-312/29/2023$20.9M$94.14M$3.00Undisclosed Investors
Eureka TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$130.85MSeries E12/16/2019$45M$359.7M$4.16Lyell Immunopharma, Acorn Pacific Ventures, GP Capital, Suma Venture, Harbinger Venture Capital, Yuan Capital, Majuven
EvommuneHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$268.46MSeries C10/31/2024$115.5M$346.35M$1.59RA Capital Management, Sectoral Asset Management, B Capital, Marshall Wace, Avego Bioscience Capital, Longwood Fund, RTW Investments, ADAR1 Capital Management, NEXTBio Capital, Beiersdorf Venture Capital, FemHealth Ventures, Allostery Investments LP, Pivotal bioVenture Partners, EQT Life Sciences, Andera Partners, Amplitude Ventures, SymBiosis, Verition Fund Management
Flare TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$290.35MSeries C6/30/2026$85M$188.49M$0.37Third Rock Ventures, Nextech Invest, Pfizer, Boxer Capital, GordonMD Global Investments, Invus, Casdin Capital, Eli Lilly and Company, Novartis, Agent Capital, Eventide Asset Management
Nabla BioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$107.26MSeries B5/15/2026$70.12M$476.82M$47.41Undisclosed Investors
Prolific MachinesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$138.13MSeries B-310/14/2026$50M$280.98M$2.77Atoms & Bits, Nant Capital, Prevail Venture Capital, Breakthrough Energy Ventures, Mayfield, SOSV, Ki Tua Fund
Recludix PharmaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$123.5MSeries B1/12/2026$21.5M$327.7M$2.31Access Biotechnology, Alexandria Venture Investments, NEA, Westlake Village BioPartners, Eli Lilly
Timberlyne TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$9.88MSeries A1/9/2025$9.37M$137.37M$3.64Abingworth, Bain Capital Life Sciences, Venrock, Boyu Capital, Lilly Asia Ventures, Braidwell, 3H Health Investment
49-72 of 186

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.